Unknown

Dataset Information

0

Diaphyseal medullary stenosis with malignant fibrous histiocytoma: a hereditary bone dysplasia/cancer syndrome maps to 9p21-22.


ABSTRACT: Diaphyseal medullary stenosis with malignant fibrous histiocytoma (DMS-MFH) is an autosomal dominant bone dysplasia/cancer syndrome of unknown etiology. This rare hereditary cancer syndrome is characterized by bone infarctions, cortical growth abnormalities, pathological fractures, and eventual painful debilitation. Notably, 35% of individuals with DMS develop MFH, a highly malignant bone sarcoma. A genome scan for the DMS-MFH gene locus in three unrelated families with DMS-MFH linked the syndrome to a region of approximately 3 cM on chromosome 9p21-22, with a maximal two-point LOD score of 5.49 (marker D9S171 at recombination fraction [theta].05). Interestingly, this region had previously been shown to be the site of chromosomal abnormalities in several other malignancies and contains a number of genes whose protein products are involved in growth regulation. Identification of this rare familial sarcoma-causing gene would be expected to simultaneously define the cause of the more common nonfamilial, or sporadic, form of MFH-a tumor that constitutes approximately 6% of all bone cancers and is the most frequently occurring adult soft-tissue sarcoma.

SUBMITTER: Martignetti JA 

PROVIDER: S-EPMC1377798 | biostudies-literature | 1999 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Diaphyseal medullary stenosis with malignant fibrous histiocytoma: a hereditary bone dysplasia/cancer syndrome maps to 9p21-22.

Martignetti J A JA   Desnick R J RJ   Aliprandis E E   Norton K I KI   Hardcastle P P   Nade S S   Gelb B D BD  

American journal of human genetics 19990301 3


Diaphyseal medullary stenosis with malignant fibrous histiocytoma (DMS-MFH) is an autosomal dominant bone dysplasia/cancer syndrome of unknown etiology. This rare hereditary cancer syndrome is characterized by bone infarctions, cortical growth abnormalities, pathological fractures, and eventual painful debilitation. Notably, 35% of individuals with DMS develop MFH, a highly malignant bone sarcoma. A genome scan for the DMS-MFH gene locus in three unrelated families with DMS-MFH linked the syndro  ...[more]

Similar Datasets

| S-EPMC6879995 | biostudies-literature
2012-01-17 | GSE32375 | GEO
2012-01-17 | E-GEOD-32375 | biostudies-arrayexpress
| S-EPMC3377825 | biostudies-literature
| S-EPMC6940612 | biostudies-literature
| S-EPMC6798660 | biostudies-literature
| S-EPMC8656228 | biostudies-literature